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CUTANEOUS BOTRYOMYCOSIS IN TWO PET RABBITS 
 
ABSTRACT 
 
A 5-year-old male neutered rabbit was presented for assessment of multiple abscesses, which 
had appeared suddenly over the ventrum, perineum and hindlimbs over the previous few 
days. Thirteen abscesses were surgically excised. Culture revealed Pseudomonas 
aeruginosa and histopathological examination confirmed a diagnosis of botryomycosis. 
However, despite follow up antimicrobial treatment and repeat surgeries, lesions continued to 
recur. The second case, a 3-year-old male neutered rabbit presented for routine vaccination. 
On physical examination, multiple small nodules were palpated over the right shoulder 
region. Surgical excision was performed and histopathology again yielded a diagnosis of 
botryomycosis. So far, no recurrence has been seen in this case. Botryomycosis is a rare 
chronic pyogranulomatous infection and naturally occurring disease has not been previously 
reported in pet rabbits. These cases highlight the challenges of treatment and the importance 
of prompt diagnosis. 
 
MANUSCRIPT 
 
Botryomycosis is a rare chronic pyogranulomatous infection which may affect the skin, 
subcutis, or visceral organs.1 Various bacteria may be involved and the pathogenesis is not 
completely understood. It is however thought that pyogranulomas develop because of a 
complex interaction between the virulence of the infectious organisms and the host response. 
This paper describes the clinical, pathological and bacteriological findings in two pet rabbits 
diagnosed with cutaneous botryomycosis. 
 
A 5-year-old male neutered cross breed rabbit was referred for assessment of multiple 
masses, which had appeared suddenly over the last few days. The first mass had been seen 
following a bite wound above the tail from another rabbit eight weeks previously and treated 
by the referring veterinarian with oral enrofloxacin (20 mg/kg once daily, Baytril Oral 
Solution, Bayer, UK) for two weeks. Over the last two days however, multiple small masses 
had appeared, some of which were discharging white purulent material. A swab of the 
discharge was taken and submitted for culture and sensitivity, but results were pending at that 
point. On initial physical examination, 9 masses were detected over the ventrum, perineum, 
hind limbs and rump, ranging in size from 2-20 mm. Otherwise, clinical examination was 
unremarkable.  
 
The following day, the rabbit was sedated with 0.05 mg/kg fentanyl and 1.5 mg/kg fluanisone 
(Hypnorm, Vetapharma Ltd, UK) by intramuscular injection.  General anesthesia was 
induced with alfaxalone (1 mg/kg , Alfaxan, Jurox, UK) by slow intravenous injection and 
following intubation, maintained with 2-3% isoflurane and 2 liter/min oxygen with 
intermittent manual positive pressure ventilation and intravenous fluid therapy was provided 
at 10ml/kg/hr with compound sodium lactate (Aquapharm No. 11, Animalcare Ltd, UK)  
throughout the procedure. On clipping for surgical preparation, 4 further masses were 
detected. Surgical excision of all masses was performed except for one 3 mm mass 
discovered during surgery, which was left in-situ on the ventral surface of the prepuce. This 
mass was not removed due to concerns of wound dehiscence in this area. Wounds were 
closed with intradermal poliglecaprone 25 suture (Monocryl, Ethicon, UK) and tissue glue 
was applied. Each of the masses appeared to contain further encapsulated microabscesses 
(Figure 1). These were submitted for histopathological examination. 
  
Following surgery, treatment was initiated with buprenorphine (0.05 mg/kg, Buprecare 
Solution for Injection, AnimalCare, UK) by subcutaneous injection and oral meloxicam (0.6 
mg/kg twice daily, Loxicom Oral Suspension, Norbrook, UK) to provide analgesia, and oral 
ranitidine (4 mg/kg twice daily, Zantac Syrup, GlaxoSmithKline, UK) to prevent gut stasis, in 
addition to supplementary syringe feeding (Critical Care formula, Oxbow Animal Health, 
USA). Antibiotic treatment was also initiated with procaine benzylpenicillin (60,000 IU/kg 
once daily, Depocillin Suspension for injection, MSD Animal Health, UK) by subcutaneous 
injection and the rabbit remained in hospital while awaiting culture results. Over the next few 
days, significant urine scalding resulted in widespread dermatitis over the ventrum and 
wound dehiscence was seen at all surgical sites, even those on the rump. The preputial lesion 
had however resolved. Urinary scalding was reported by the owner at times of stress and 
previous investigations by the referring veterinarian had not indicated any underlying urinary 
problem. Frequent cleaning and topical treatment of the wounds were performed with a 
combination of dilute chlorhexidine (Hibiscrub, Mölnlycke Health Care Limited, UK), F10 
ointment (F10® Germicidal Barrier Ointment, F10 Products Limited, South Africa) and 
Manuka honey (Activon, Advancis Medical, UK). Supportive treatment with analgesics, 
prokinetics, antibiotics and supplementary feeding were continued. 
 
Culture results revealed a profuse growth of Pseudomonas aeruginosa sensitive to amikacin, 
gentamicin, enrofloxacin and marbofloxacin. Histopathological examination revealed that the 
dermis was multifocally expanded by coalescing nodules which comprised large numbers of 
macrophages and heterophils centered on large colonies of gram-positive cocci surrounded 
by brightly eosinophilic amorphous (Splendore-Hoeppli) material.  In one section there was 
focal epidermal ulceration. The masses examined were consistent with a deep dermal 
bacterial infection, such as botryomycosis (Figures 2 and 3).  
 
As previous treatment with enrofloxacin had not completely resolved the first mass, treatment 
was initiated with marbofloxacin (5 mg/kg, Marbocyl Solution for Injection, Vetoquinol UK 
Ltd, UK) once daily by intravenous injection in addition to the previous treatment with 
procaine penicillin. Wound healing was slow and metronidazole was also initiated at 20 
mg/kg twice daily initially by the intravenous route (Metronidazole injection, Baxter, UK) for 
the first five days and then orally (Metronidazole oral suspension, Rosemont, UK). The rabbit 
remained in hospital for a total of 28 days on continued treatment. At this point, a further 
small abscess was noted under the skin in the left inguinal region and the rabbit’s appetite and 
fecal output had reduced. Repeat surgery was considered, but the owner opted to take the 
rabbit home to continue on oral medications, due to concerns that the stress of hospitalization 
was increasing the urine scalding and hence reducing the chance of skin healing. 
 
Three weeks later, the rabbit was re-presented for further assessment. Appetite, fecal output 
and urine scalding had resolved at home and all surgical wounds had now completely healed. 
However, on examination, the left inguinal mass noted previously had increased in size and 4 
other masses had developed over the inguinal region and rump despite continued antibiotic 
treatment. The rabbit was therefore admitted for further investigations and surgery. A blood 
sample was submitted for hematology and biochemistry. Triglyceride levels were elevated at 
5.24 (reference interval 1.4-1.76) mmol/L 2 which was consistent with the calorie dense 
critical care diet being fed to stimulate appetite since returning home. Occasional reactive 
lymphocytes were noted on examination of blood smears, but otherwise all results were 
within normal limits. An abdominal ultrasound was performed to investigate the presence of 
internal focuses of infection, but no abnormalities were detected. 
 
General anesthesia and surgical excision of masses were performed as previously described 
but again, further abscesses were detected following clipping. Samples were submitted for 
both tissue culture and histopathological examination. The rabbit recovered well from the 
procedure and was taken home the following day on continued treatment as previously 
described while awaiting results to reduce any stress caused by hospitalization. 
Histopathology results again revealed severe chronic multifocal pyogranulomatous dermatitis 
and steatitis, with intra-lesional bacteria and Splendore-Hoeppli formation. However, gram 
staining this time revealed gram-negative intra-lesional bacteria. This was in accordance with 
tissue culture results which revealed a profuse growth of Pseudomonas aeruginosa and 
Stenotrophomonas maltophilia. Initial sensitivity results revealed the Pseudomonas to now be 
resistant to enrofloxacin and marbofloxacin on disc diffusion tests, but minimal inhibitory 
concentration (MIC) testing reported the isolate to still be sensitive to these antimicrobials. 
Due to the recurrent nature of the disease process, euthanasia was discussed with the owners. 
However, the owners opted to continue treatment. Therefore, oral marbofloxacin dosage was 
increased to 10mg/kg once daily, while the procaine benzylpenicillin and metronidazole were 
discontinued.  
 
Over the subsequent 6 months, masses continued to recur despite ongoing treatment with 
marbofloxacin and meloxicam. Repeat surgeries were performed to completely excise 
affected tissue as previously described and marsupialization techniques were also attempted 
to allow topical treatment with gentamicin (Tiacil Ophthalmic Solution, Virbac Limited, 
UK). Repeat tissue culture results again confirmed Pseudomonas aeruginosa infection, but 
with development of resistance to enrofloxacin and marbofloxacin based on MIC and disc 
diffusion. Potential health and safety risks were discussed with the owner, but they opted to 
continue palliative treatment. Nine months following initial presentation, the rabbit developed 
myiasis and died despite supportive care administered by the referring veterinarian. Post-
mortem examination was declined by the owner. 
 
 
A 3-year-old male neutered cross breed rabbit was presented for routine vaccination. No 
concerns were reported, but on physical examination, multiple small nodules were palpated 
over the right shoulder region varying from 5-8 mm in diameter. No known traumatic cause 
could be identified, although another rabbit was in contact, so an undetected bite wound was 
possible. Clinical examination was otherwise unremarkable and the rabbit was admitted for 
excisional biopsies of the affected region immediately. Under general anesthesia, the whole 
affected area was removed with ~ 15 mm surgical margins. Each of the masses contained 
further encapsulated microabscesses. These were submitted for tissue culture and 
histopathological examination. Wounds were closed with intradermal poliglecaprone 25 
sutures. Histopathology revealed multilobulated and partially encapsulated abscesses, 
composed of numerous degenerate heterophils and macrophages, expanding the dermis and 
elevating the epidermis. Rarely heterophils were observed surrounding 20-80 μm diameter 
club-shaped colonies of 2-4 μm coccoid gram-positive bacteria surrounded by Splendore-
Hoeppli material, consistent with a diagnosis of botryomycosis. Aerobic microbiology culture 
did not yield any bacterial growth. Recovery from anesthesia and surgery was uneventful and 
no recurrence was noted for 12 months. 
 
Discussion 
 
Botryomycosis is a chronic pyogranulomatous disease, previously described in humans and a 
variety of companion and farm animal species including equids, cattle, dogs, hamsters, mice 
and guinea pigs.1-, 3-8 It has also been reported in a number of wild mammals including 
African elephants, barbary ape and harp seals.9-11 Naturally occurring disease has not been 
previously reported in rabbits. The exact pathogenesis is not completely understood, but it is 
thought that pyogranulomas develop because of a complex interaction between the virulence 
of the infectious organisms and the host response.12 The most common bacteria involved is 
Staphylococcus aureus, followed by Pseudomonas aeruginosa, although other bacteria such 
as Proteus spp, Escherichia coli and Streptococcus spp have been reported.1  Anaerobic 
agents are occasionally involved, but anaerobic culture was unfortunately not performed in 
the cases reported herein. Disease appears to follow a traumatic injury and in humans, most 
patients have an altered immune response or are suffering from concurrent disease.13 In the 
first rabbit case seen, a bite injury preceded the development of these lesions, although the 
relationship between the two events cannot be proven. There appeared to be a combination of 
infectious agents involved including gram-positive cocci identified on initial microscopic 
examination and, subsequently, at least one strain of Pseudomonas aeruginosa. The variation 
in sensitivity results indicate that a mixed culture is most likely in this case.  In the second 
case, no obvious traumatic injuries had been reported by the owner, but due to the dense coat, 
a small puncture wound could potentially have been missed. Pathogen concentration may 
also be a factor. In a study in laboratory rabbits, botryomycosis did not develop when either 
low or high concentrations of S. aureus were used to induce experimental infection, but was 
seen when intermediate concentrations were used.14  
 
In other species, lesions frequently affect the skin, but a visceral form also exists. This can 
either be a primary disease process or secondary to cutaneous infection.1 In visceral disease, 
the lungs are frequently involved, although other organs including the liver, kidney, heart and 
brain may be affected.1, 15-17 In these rabbit cases, there was no evidence of visceral disease, 
although as no post-mortem examination was performed on the first rabbit and no imaging on 
the second rabbit, this cannot be completely ruled out. Definitive diagnosis is based on 
histopathological evaluation which usually reveals characteristic heterophilic or 
granulomatous inflammation surrounding bacteria which are bordered by Splendore-Hoeppli 
material (thought to be necrotic debris admixed with antibody/antigen complexes).18  
 
The therapy of choice for botryomycosis is surgical excision of visible lesions combined with 
prolonged antibiotic treatment which can extend for at least six months. Any 
immunosuppressive factors should also be controlled.1  However, systemic antibiotic therapy 
may not always be effective due to failure of antibiotics to penetrate the granulomas.19 
Relapses appear common, as occurred in the first case and treatment is often only palliative. 
The potential welfare concerns of managing a case such as this should therefore be 
considered and discussed with owners. Euthanasia may need to be considered for severely 
affected or recurrent cases. The cutaneous form has been reported to be non-pruritic and non-
painful in humans, but signs depend on location and size of lesions.20 The first case remained 
on meloxicam long-term following initial diagnosis, as the location of the lesions were 
considered to potentially be a source of pain. The potential health and safety risks to other 
animals and humans of keeping a rabbit with a multiresistant bacterial infection should also 
be considered, although no cases of zoonotic spread from botryomycosis have been reported. 
 
In conclusion, botryomycosis should be considered as a differential for cutaneous masses in 
rabbits, in particular recurrent atypical abscesses. Tissue culture and histopathological 
examination is recommended for these cases and if diagnosed, prompt surgical treatment is 
likely to be necessary for the best outcome. 
 
FIGURE LEGENDS 
 
 
Figure 1 – Initial surgical excision of masses 
 
Figure 2 – Haired skin, rabbit. The dermis and subcutis are expanded and replaced by 
multiple nodules of pyogranulomatous inflammation. H&E (x20) 
 
Figure 3 – Haired skin, rabbit. Large colony of coccoid bacteria surrounded by degenerate 
heterophils admixed with Splendore-Hoeppli material.  Gram stain (x 400) 
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